23andMe Newsletter: Limited time: $70 off Health + Ancestry Kit

Published by 23andMe on August 22nd, 2022 12:10pm. 8 views.

Follow 23andMe: Website

You might also like: 23andMe Coupons & Promotions on Contaya.com

About this post - by PublicEmails.com:

This is an email newsletter from 23andMe about a limited-time offer for a Health + Ancestry Kit. The offer is $129, a $70 discount from the regular price of $199. The kit includes 150+ personalized reports on ancestry, traits, health, and more. It also includes everything in the Ancestry + Traits Service and FDA-authorized reports. The offer is available for a limited time and ends on September 5, 2022. The newsletter also includes links to 23andMe's social media pages, as well as information about the company.

In Spanish:

Este es un boletín informativo de 23andMe sobre una oferta por tiempo limitado del "Health + Ancestry Kit". La oferta es de $129, un descuento de $70 sobre el precio normal de $199. El kit incluye más de 150 informes personalizados sobre ancestría, rasgos, salud y más. También incluye todo lo del servicio de ancestría + rasgos e informes autorizados por la FDA. La oferta está disponible por tiempo limitado y finaliza el 5 de septiembre de 2022. El boletín informativo también incluye enlaces a las páginas de redes sociales de 23andMe, así como información sobre la empresa.

23andMe

View email in your browser.

Refocusing on your health?

We’ve got you.

$129

Health + Ancestry Kit
Reg $199

Shop now

Limit 6 kits. Offer ends Sep 5.

What you get

150+ personalized reports on ancestry, traits, health more

Includes everything in our Ancestry + Traits Service

Includes FDA-authorized reports*

FSA/HSA eligibility

Shop now

Savings based on regular price $199/kit. Offer is valid in a single order at checkout on 23andMe.com, placed after clicking in this email. Cannot be combined or used with any other discount, promotion or special pricing and cannot be applied to previous purchases. Offer ends September 5, 2022 at 11:59 PM PT.

*The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet US FDA requirements for genetic health risks and the 23andMe Type 2 Diabetes health predisposition report which is based on 23andMe research and has not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child’s risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. For important information and limitations regarding each genetic health risk and carrier status report, visit 23andme.com/test-info/.

© 2007 - 2022 23andMe, Inc.
23andMe, Inc. 223 N. Mathilda Avenue, Sunnyvale, CA 94086, USA

from 23andMe news and updates emails